Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer
- 1 December 1990
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 815-821
- https://doi.org/10.1016/0960-0760(90)90425-k
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Growth factor expression in Breast tissueThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumorsThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failureThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatinBreast Cancer Research and Treatment, 1989
- Prognostic value of epidermal growth factor receptor in node-positive breast cancerBreast Cancer Research and Treatment, 1989
- The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancerCancer, 1989
- Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerJournal of Clinical Laboratory Analysis, 1989
- Presence and characterization of insulin-like growth factor 1 receptors in human benign breast diseaseEuropean Journal of Cancer and Clinical Oncology, 1988
- Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomasGynecologic Oncology, 1988
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975